And it goes up 33%? Makes no sense to me.
My son left and could not be happier at his new job. He always felt that BXC shared a niche where only the nimble survive. He felt that BXC carrying the dog and its analyst load and its debt load and its rental load meant BXC had a hard time standing up much less being nimble. We will know if BXC ever gets off the balls of its arese because the dog will take whatever equity BXC can generate. Employees - hang in there and hope your resume gets somewhere that BXC employment does not poison your chances.
beware - I never said you were short.I said that shorty has his people on early on a sat morning trying to make sure this does not rebound once the retail emotion crowd aided by the short manipulating is over. My bet is hard against shorty with a one year timeline, but who knows over the next 3 or 4 days. Lots of retail emotion players and some of them will wake up Monday morning and sell in a panic. If they do, I will buy. And have a good day.
OK you got me. I make the following mods to my post:
Breakthru status practically guarantees early approval
1 year from now will likely be treating TNBC patients
bewareofshiills is the only person in the world who remembers what happened in the 2015 ASCO. Anyone who can't remember the 2015 ASCO today is not likely to remember the 2016 ASCO a year from now.
Only an idiot would pass on a 25% off sale
Likely timeline of 3 months to a year, buy all you can get
I would add that shorty has one of his shills working this board on Sat. morning. Sure sign shorty is worried about a rebound and trying to ensure one does not catch him/her with his/her pants down.
Oh - and have a good day shorty.
"No reason to believe this hype!" = bewareofshills
Bewareof - what hype? Breakthru status? Phase 3? FDA impressed with TNBC results enough to give breakthru status? Price dropped? What hype????? fact check each statement. 15 minute DD proves that all I said is true. You Mr. beware of are the shill and it is for the short stinkers.
Buy hand over fist this co with breakthru status. 1 year from now, no one will remember 2016 ASCO fiasco but IMMU will be treating TNBC patients who had no other drug to use. Results are compelling, phase is 3, and BTS will guarantee an early approval. Add in the recent stock sale price of 20 to 25% off and you have a compelling purchase. Time line 1 year, buy all you can get. Time line 3 days - who knows what shorty will do. Buy all you can, but no margin given 3 day outlook.
Georgebushky = "Originally posted this on the morning of May 19, 2016. Reposted to clean up some angry posts from the Pumper crowd. Thank you."
I have reviewed all posts from May 19 and George did not post this on that day. He is a liar